|
Volumn 12, Issue 1, 2006, Pages 27-
|
Rimonabant adds appetizing choice to slim obesity market
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 CHLORO N [[3 (4 CHLOROPHENYL) 4 PHENYL 2 PYRAZOLIN 1 YL](METHYLAMINO) METHYLENE]BENZENESULFONAMIDE;
4 CHLORO N [[3 (4 CHLOROPHENYL) 4 PHENYL 2 PYRAZOLIN 1 YL](METHYLAMINO)METHYLENE]BENZENESULFONAMIDE;
ANTIOBESITY AGENT;
AOD 9604;
APD 356;
ATL 962;
CETILISTAT;
CP 946 598;
CP 946598;
PHENTERMINE;
PYY 3 36;
RIMONABANT;
SIBUTRAMINE;
TETRAHYDROLIPSTATIN;
UNCLASSIFIED DRUG;
ABDOMINAL PAIN;
ANOREXIA;
ARTHRALGIA;
CLINICAL TRIAL;
CONSTIPATION;
DIARRHEA;
DIZZINESS;
DRUG INDUCED HEADACHE;
DRUG MONITORING;
DRUG SURVEILLANCE PROGRAM;
FECES INCONTINENCE;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL SYMPTOM;
HEART PALPITATION;
HUMAN;
HYPERTENSION;
INSOMNIA;
MORBID OBESITY;
NAUSEA;
NOTE;
PRIORITY JOURNAL;
STEATORRHEA;
TACHYCARDIA;
TREMOR;
XEROSTOMIA;
APPETITE DEPRESSANTS;
DRUG EVALUATION;
DRUG INDUSTRY;
HUMANS;
OBESITY;
PIPERIDINES;
PYRAZOLES;
WEIGHT LOSS;
|
EID: 30044448658
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0106-27 Document Type: Note |
Times cited : (13)
|
References (0)
|